Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain.
S N Liossis, … , G J Dennis, G C Tsokos
S N Liossis, … , G J Dennis, G C Tsokos
Published April 1, 1998
Citation Information: J Clin Invest. 1998;101(7):1448-1457. https://doi.org/10.1172/JCI1457.
View: Text | PDF
Research Article Article has an altmetric score of 6

Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain.

  • Text
  • PDF
Abstract

Cellular immunity aberrations in patients with SLE are underscored by the abnormal early Ag receptor-mediated lymphocyte signal transduction pathway. To further characterize the T cell receptor (TCR)/CD3-initiated signaling defects, we studied 22 patients with SLE, 12 patients with other systemic rheumatic diseases, and 14 normal donors. The early (1 min) TCR/CD3-mediated tyrosine phosphorylation of cellular proteins with a molecular size between 36 and 64 kD was increased in 15 of 21 SLE patients, compared to normal or disease control subjects. The deficiency or absence of a band with a molecular size of approximately 16 kD in the immunoblots of SLE patients led us to investigate the expression of the TCRzeta chain. In immunoblots using anti-zeta antibodies we found that 10 of 22 lupus patients tested lacked the expression of TCRzeta, which was always present in control subjects (P < 0.001). Flow cytometric studies using permeabilized cells confirmed the deficiency or absence of the TCRzeta chain in lupus T cells. Using Northern blots we found that for eight patients tested, the TCRzeta mRNA was missing in three, decreased in three, and apparently normal in two patients (P < 0.003), but was always present in control subjects. Reverse transcriptase-PCR verified Northern blot results. We conclude that TCRzeta chain expression is either decreased or absent in the majority of patients with SLE, but not in patients with other systemic rheumatic diseases, regardless of disease activity, treatment status, or clinical manifestations. The previously described increases in TCR-initiated Ca2+ responses and the herein described increases in TCR-induced protein tyrosine phosphorylation and deficient TCRzeta expression may represent intrinsic defects modulating lupus T cell function.

Authors

S N Liossis, X Z Ding, G J Dennis, G C Tsokos

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1991 Total
Citations: 2 7 4 4 2 1 3 8 4 6 5 6 12 11 14 16 8 10 11 15 15 23 19 13 18 13 3 8 1 262
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2011 (14)

Title and authors Publication Year
The problem of accelerated atherosclerosis in systemic lupus erythematosus: Insights into a complex co-morbidity :
NS Wade, AS Major
Thrombosis and Haemostasis 2011
Harnessing programmed cell death as a therapeutic strategy in rheumatic diseases
M Ramaswamy, M Deng, RM Siegel
Nature reviews. Rheumatology 2011
Abnormalities of T cell signaling in systemic lupus erythematosus
VR Moulton, GC Tsokos
Arthritis Research & Therapy 2011
Targeting lymphocyte signaling pathways as a therapeutic approach to systemic lupus erythematosus
VC Kyttaris, GC Tsokos
Current Opinion in Rheumatology 2011
SLAMF6-driven co-stimulation of human peripheral T cells is defective in SLE T cells
M Chatterjee, K Kis-Toth, TH Thai, C Terhorst, GC Tsokos
Autoimmunity 2011
Tumor-dependent down-regulation of the ζ-chain in T-cells is detectable in early breast cancer and correlates with immune cell function
JD Boniface, I Poschke, Y Mao, R Kiessling
International Journal of Cancer 2011
Tissue-Specific Expression of Human Calcineurin-Binding Protein 1 in Mouse Synovial Tissue Can Suppress Inflammatory Arthritis
DH Yu, JK Yi, SJ Park, MO Kim, HJ Kim, HS Yuh, KB Bae, YR Ji, HS Lee, SG Lee, YS Choo, JY Kim, DH Yoon, BH Hyun, ZY Ryoo
Journal of Interferon & Cytokine Research 2011
Development of unique antibodies directed against each of the six different phosphotyrosine residues within the T cell receptor CD3ζ chain
S Gelkop, B Weisman, RN Pulak, D Zharhary, N Isakov
Journal of Immunological Methods 2011
Linker for activation of t cells is displaced from lipid rafts and decreases in lupus t cells after activation via the tcr/cd3 pathway
N Abdoel, S Brun, C Bracho, MA Rodríguez, AM Blasini
Clinical Immunology 2011
Biologic Agents in the Treatment of Systemic Lupus Erythematosus
VC Kyttaris
Systemic Lupus Erythematosus 2011
T-Cells and Systemic Lupus Erythematosus
JC Crispín, GC Tsokos
Systemic Lupus Erythematosus 2011
Galectin-1-induced down-regulation of T lymphocyte activation protects (NZB x NZW) F1 mice from lupus-like disease
SD Liu, S Lee, AL Cava, CC Motran, BH Hahn, MC Miceli
Lupus 2011
A systemic lupus erythematosus gene expression array in disease diagnosis and classification: a preliminary report
YT Juang, C Peoples, R Kafri, VC Kyttaris, K Sunahori, K Kis-Toth, L Fitzgerald, S Ergin, M Finnell, GC Tsokos
Lupus 2011
Expression and function of Cbl-b in T cells from patients with systemic lupus erythematosus, and detection of the 2126 A/G Cblb gene polymorphism in the Mexican mestizo population
L Doníz-Padilla, V Martínez-Jiménez, P Niño-Moreno, C Abud-Mendoza, B Hernández-Castro, R González-Amaro, E Layseca-Espinosa, L Baranda-Cándido
Lupus 2011

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
Referenced in 1 Wikipedia pages
46 readers on Mendeley
See more details